Please login or register first to view this content.
Dermatological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Adbry Approved for Moderate to Severe Atopic Dermatitis
Spesolimab Clears Lesions in Generalized Pustular Psoriasis
Trial Evaluating Lebrikizumab Plus TCS in Atopic Dermatitis Meets Endpoints
Otezla Now Approved for Plaque Psoriasis Across All Severities
Ligelizumab Not Superior to Omalizumab in Chronic Spontaneous Urticaria Trials
MPR Weekly Dose Podcast Episode 102
FDA to Review Drug-Device Combo for Molluscum Contagiosum Treatment
Ruxolitinib Cream Gets Priority Review for Vitiligo Treatment
Rinvoq Approved for Active Psoriatic Arthritis
Outcomes Worse for Hospitalized Patients With Incontinence
Treatments Explored for Moderate-to-Severe Alopecia Areata
Clinically Significant Improvements in Genital Psoriasis Observed With Apremilast
Deucravacitinib Under Review for Moderate to Severe Plaque Psoriasis
Atopic Dermatitis Linked to Shorter Stature in Early Childhood
Review Profiles Open-Access Datasets With Skin Cancer Images
Oral Nadolol Feasible for the Treatment of Infantile Hemangiomas
FDA Grants Fast Track Designation to Orismilast for Atopic Dermatitis
Acne Vulgaris Treatment Winlevi Now Available
